Women's Health

No association between opioids, breast cancer recurrence

No association between opioids, breast cancer recurrence

There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.

In breast cancer survivors, lidocaine may relieve pain during intercourse

In breast cancer survivors, lidocaine may relieve pain during intercourse

Breast cancer survivors who experience pain or discomfort during sexual intercourse may benefit from applying liquid lidocaine to the vulvar area.

Abnormal prenatal testing, subsequent diagnosis of maternal cancer examined

Abnormal prenatal testing, subsequent diagnosis of maternal cancer examined

Small number of occult malignancies subsequently diagnosed among pregnant women whose results showed chromosomal abnormalities.

Generic meds may boost survival in some early breast cancers

Generic meds may boost survival in some early breast cancers

More evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in early breast cancer.

Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer

Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer

Aromatase inhibitors significantly decrease the risk of death in postmenopausal women with estrogen receptor-positive breast cancer.

More radiation may decrease breast cancer recurrence risk in some patients

More radiation may decrease breast cancer recurrence risk in some patients

Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.

Benefits of mammography may be statistically overestimated

Contrary to popular expectations, the rates of advanced breast cancer have not generally declined in a number of countries where mammography screening is employed.

State regulations associated with late-stage cancer diagnoses

State regulations associated with late-stage cancer diagnoses

State regulations of health insurance and practitioners are significantly associated with time receive breast or colorectal cancer diagnoses.

Extended-field IMRT does not increase risk of duodenal toxicity

Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.

Chemotherapy dosages in overweight or obese patients with ovarian cancer

Overweight or obese patients with ovarian cancer are typically given lower per-pound chemotherapy doses to reduce toxic side effects, which could impact their survival chances.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs